Top 5 Key Players companies in Diabetic neuropathy by Most Patent Citation in the Italy in 2019 – Discovery

Free Trial

The Diabetic neuropathy top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Citation Diabetic neuropathy Key Players in the Italy. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

1	Newron Pharmaceuticals SpA	Lombardia, Italy	Safinamide,Health care,Levodopa, ...[+2]	patent citation: 258
2	Sigma-Tau Industrie Farmaceutiche Riunite SpA	Lazio, Italy	Clinical trial,Medicine,Scientific institution, ...[+2]	patent citation: 68
3	CHIESI Farmaceutici SpA	Emilia-Romagna, Italy	Inhaler,Neonatology,Medicine, ...[+2]	patent citation: 3
4	Rottapharm SpA	Lombardia, Italy	Pharmaceutics,Medicine,Orphan drug, ...[+2]	patent citation: 0
5	Alfasigma SpA	Emilia-Romagna, Italy	Internationalization,Gastrointestinal agent,Clinical trial, ...[+2]	patent citation: 0

Page generation time: Jun 23 2025

Top 5 Key Players companies in Diabetic neuropathy
by Most Patent Citation in the Italy in 2019

Key Players

Fast-growings

Startups & Unicorns

New Entrants

2022

2021

2020

2019

2018

Global

China

Japan

India

United States

Switzerland

South Korea

Italy

Spain

Netherlands

United Kingdom

Germany

France

Canada

Denmark

Most Patent Filings

Highest Patent Value

Most Patent Citation

Who we serve

Why Discovery

Social media

Try Discovery